Drug recall · June 20, 2018
Allergan Taytulla Softgel Capsules recall
Why: Contraceptive Tablets Out of Sequence.
Class I: a reasonable chance the product could cause serious harm or death.
The recall
- Product
Allergan Taytulla Softgel Capsules, 1 mg/20 mcg, 6x28 blister card Physicians's Sample - Not for Sale Distributed by: Allergan USA INC Irvine, CA 92612 NDC 0023-5862-28 (Blister Card) NDC 0023-5862-29 (Blister Carton) NDC 0023-5862-31 (Outer carton) UPC 300235862290
- Lots / codes
Lot# 5620706, Exp. 05/19
- Quantity
- 168,768 blister cards (4,725,504 softgel capsules)
- Company
- Allergan, PLC., Madison, NJ
- Distribution
- US Nationwide
- Initiated
- May 24, 2018 · Voluntary: Firm initiated
- Classified
- June 15, 2018
- Reported
- June 20, 2018
- Ended
- May 19, 2022
- How notified
- Letter
The drug: prices, other makers, shortages
If you have this product
- Check the lot number on your package against the lots above. Only those lots are recalled.
- Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
- Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
- Return or dispose of recalled product as the company or your pharmacy advises.
Questions about this recall
No comments yet. Questions, tips, what worked for you - start the conversation.
Watch Ethinyl estradiol / norethindrone
One email when the price moves, a recall or shortage is posted, or the label changes. Plus the monthly biggest-movers report. Unsubscribe in one click.